2nd International Conference on Pharmacology & Gene Therapy for Tinnitus 2 October 2025 (UK-based virtual event)
After the success of the First International Conference on Pharmacology & Gene Therapy for Tinnitus in June 2024, we are pleased to announce the second conference planned for October 2025. The aim of this conference is to bring together researchers and clinicians from the fields of hearing science, pharmacology, and gene therapy to share their perspectives and scientific discoveries that can guide future development of tinnitus treatments. For information about the first conference click here.
Target audience: Healthcare professionals and members of public are welcome to attend.
KEY TOPICS:
- How to guide future developments in pharmacology and gene therapy for tinnitus by exploring:
- Mechanics of the cochlea
- Cochlear synaptopathy
- Structural & functional brain abnormalities
- Psychoacoustic and audiological characteristics of tinnitus
- Psychiatric mechanism of tinnitus distress
- Similarities and differences between dreams, hallucinations, unexplained sensory experiences, and tinnitus
- How to assess the effectiveness of future pharmacological interventions and gene therapy for tinnitus?
- What side effects for future drugs or gene therapy for tinnitus can be predicted?
- The legislations for gene therapy and its implications for tinnitus treatment
- How to identify specific patient population who might benefit from a certain medication?
- Can food supplements help tinnitus or improve tinnitus management outcomes?
- Preventative treatments for tinnitus
Submit your abstract by Tuesday 10th June 2025 via admin@hashirtinnitusclinic.com
Registration
Early bird registration fee (if you register by 15th January 2025): £45
Standard registration fee (if you register after 15th January 2025): £95
To register, please complete and submit the form below. We will send you the details via email.
